Login / Signup

Assessment of novel prognostic biomarkers to predict pathological complete response in patients with non-metastatic triple-negative breast cancer using a window of opportunity design.

Chitradurga Rajashekhar AkshathaDhanapathi HalanaikRajesh Nachiappa GaneshNanda KishorePrasanth GanesanSmita KayalHarichandra KumarBiswajit Dubashi
Published in: Therapeutic advances in medical oncology (2024)
The validated biomarker score will help to personalize NACT protocols in patients in TNBC planned for definitive treatment.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • squamous cell carcinoma
  • small cell lung cancer
  • prognostic factors
  • radiation therapy
  • locally advanced
  • replacement therapy